Citigroup’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Citigroup’s Portfolio GHSI Stock Details GHSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-373	Closed	-$2.07K	–	6051
2024 Q3	$2.07K	Hold	373	–	–	﹤0.01%	5412
2024 Q2	$3.77K	Hold	373	–	–	﹤0.01%	5290
2024 Q1	$3.37K	Hold	373	–	–	﹤0.01%	5355
2023 Q4	$1.95K	Hold	373	–	–	﹤0.01%	5424
2023 Q3	$2.78K	Hold	373	–	–	﹤0.01%	4875
2023 Q2	$2.84K	Hold	373	–	–	﹤0.01%	5247
2023 Q1	$2.28K	Buy	373 +1	+0.3%	+$7	﹤0.01%	5080
2022 Q4	$2.7K	Hold	372	–	–	﹤0.01%	5162
2022 Q3	$3K	Hold	372	–	–	﹤0.01%	5434
2022 Q2	$3K	Sell	372 -138	-27%	-$1.21K	﹤0.01%	5818
2022 Q1	$6K	Buy	510 +138	+37%	+$2.8K	﹤0.01%	5775
2021 Q4	$12K	Buy	+372	New	+$20K	﹤0.01%	5533

Citigroup's GHSI Position: Q4 2024 in Review

Citigroup sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 373 shares — an estimated $2.07K sold.

Citigroup first reported a position in GHSI in Q4 2021 and held it in 12 quarters. The position peaked at $12K in Q4 2021. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.

Citigroup reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Citigroup sold 373 Guardion Health Sciences, Inc. Common Stock shares in Q4 2024, an estimated $2.07K.
Citigroup first reported a position in Guardion Health Sciences, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
Citigroup's Guardion Health Sciences, Inc. Common Stock position peaked at $12K in Q4 2021.
0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.

Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.